1,3-dipropyl-8-cyclopentylxanthine and peoniflorin

1,3-dipropyl-8-cyclopentylxanthine has been researched along with peoniflorin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, JT; Hsu, FL; Lai, CW1
Cheng, JT; Hsu, FL; Wang, CJ1
Matsumoto, K; Murakami, Y; Tabata, K; Watanabe, H1
Cheng, JT; Liu, IM; Tang, LM1
Ji, XQ; Jiang, CL; Liu, DZ; Xie, KQ; Ye, Y; Zhu, XZ1
Hu, J; Huo, X; Li, J; Liu, Q; Ma, S; Sun, J; Sun, L; Wang, H; Zhao, M1

Other Studies

6 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and peoniflorin

ArticleYear
Stimulatory effect of paeoniflorin on adenosine A-1 receptors to increase the translocation of protein kinase C (PKC) and glucose transporter (GLUT 4) in isolated rat white adipocytes.
    Life sciences, 1998, Volume: 62, Issue:17-18

    Topics: Adipocytes; Alkaloids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Benzophenanthridines; Bridged-Ring Compounds; Cell Membrane; Cytosol; Drug Interactions; Enzyme Inhibitors; Glucose Transporter Type 4; Glucosides; Isoenzymes; Monosaccharide Transport Proteins; Monoterpenes; Muscle Proteins; Phenanthridines; Phosphorylation; Protein Kinase C; Protein Kinase C beta; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Signal Transduction; Stimulation, Chemical; Xanthines

1998
Paeoniflorin reverses guanethidine-induced hypotension via activation of central adenosine A1 receptors in Wistar rats.
    Clinical and experimental pharmacology & physiology, 1999, Volume: 26, Issue:10

    Topics: Adrenergic Agents; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Blood Pressure; Bridged-Ring Compounds; Dose-Response Relationship, Drug; Glucosides; Guanethidine; Hypotension; Male; Monoterpenes; Plants, Medicinal; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Xanthines

1999
Ameliorative effects of paeoniflorin, a major constituent of peony root, on adenosine A1 receptor-mediated impairment of passive avoidance performance and long-term potentiation in the hippocampus.
    Biological & pharmaceutical bulletin, 2001, Volume: 24, Issue:5

    Topics: Adenosine; Animals; Avoidance Learning; Benzoates; Bridged-Ring Compounds; Glucosides; Hippocampus; Long-Term Potentiation; Male; Mice; Monoterpenes; Rats; Rats, Wistar; Receptors, Purinergic P1; Xanthines

2001
Stimulatory effect of paeoniflorin on adenosine release to increase the glucose uptake into white adipocytes of Wistar rat.
    Planta medica, 2003, Volume: 69, Issue:4

    Topics: Adenosine; Adipocytes; Animals; Benzoates; Bridged-Ring Compounds; Carbon Radioisotopes; Deoxyglucose; Dose-Response Relationship, Drug; Glucose; Glucosides; Male; Monoterpenes; Paeonia; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Xanthines

2003
Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonists.
    British journal of pharmacology, 2005, Volume: 146, Issue:4

    Topics: Adenosine-5'-(N-ethylcarboxamide); Animals; Benzoates; Binding, Competitive; Bridged-Ring Compounds; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Glucosides; Infarction, Middle Cerebral Artery; Inhibitory Concentration 50; Ischemic Attack, Transient; Male; Monoterpenes; Neuroprotective Agents; Paeonia; Plant Roots; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Time Factors; Xanthines

2005
ADAM17 participates in the protective effect of paeoniflorin on mouse brain microvascular endothelial cells.
    Journal of cellular physiology, 2018, Volume: 233, Issue:12

    Topics: ADAM17 Protein; Animals; Brain; Cell Line; Cell Membrane; Cell Survival; Endothelial Cells; ErbB Receptors; Glucosides; Hydrogen Peroxide; Mice; Microvessels; Models, Biological; Monoterpenes; Neuroprotective Agents; Phosphorylation; Receptor, Adenosine A1; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Solubility; src-Family Kinases; Transcriptional Activation; Xanthines

2018